4.6 Article

TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs

期刊

CELL CYCLE
卷 18, 期 1, 页码 60-68

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2018.1558870

关键词

Proteotoxic stress; TRIM11; cell viability; anti-tumor; HSF1

资金

  1. National Institutes of Health [R01CA182675, R01CA184867]
  2. National Natural Science Foundation of China [31801186]
  3. Wealth Strategy Holding Limited

向作者/读者索取更多资源

Cells mainly rely on stress proteins, such as heat-shock proteins (HSPs), to respond to various proteotoxic conditions. These proteins protect tumor cells and enhance their survive. However, the regulation of stress proteins involved in protein quality control (PQC) is still poorly understood. Here, we report that the expression of TRIM11, an important regulator of PQC, is positively correlated with tumor cell surviaval during the proteotoxic conditions induced by anti-tumor drugs. In addition, HSF1 is required for TRIM11-mediated removal of protein aggregates and resistance of proteotoxic stress. During these processes, TRIM11 interacts with and stabilizes HSF1, increaseing HSF1 levels in the nucleus. These findings identify that TRIM11, through cooperation with HSF1, protects cells against the proteotoxic stress and promotes tumor cell survival.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据